Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4402051000168114 | Ferrovance C (ascorbic acid 500 mg + ferrous sulfate 325 mg) modified release tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4402061000168111 | Ferrovance C modified release tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ferrovance C modified release tablet, 30, bottle | has TPUU | True | Ferrovance C modified release tablet | Inferred relationship | Some | 1771128716 |
Ferrovance C modified release tablet, 30 | has TPUU | True | Ferrovance C modified release tablet | Inferred relationship | Some | 162519213 |
Reference Sets
Unit of use quantity reference set
Trade product unit of use reference set